P

Inventor

OKAMOTO HARUKA

US20 patents
⚠️ This page may combine multiple inventors who share the name “OKAMOTO HARUKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

17 patents
US9587029B2Mar 7, 2017

Human antibodies to the glucagon receptor and methods of use thereof

REGENERON PHARMA15 citations91
US9358287B2Jun 7, 2016

Method of treating stress hyperglycemia with human antibodies to the glucagon receptor

REGENERON PHARMA21 citations91
US9127068B2Sep 8, 2015

Nucleic acids encoding human glucagon receptor antibodies

REGENERON PHARMA20 citations91
US9657099B2May 23, 2017

Anti-glucagon antibodies

REGENERON PHARMA10 citations84
US8771696B2Jul 8, 2014

Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor

REGENERON PHARMA12 citations83
US10233250B2Mar 19, 2019

Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels

REGENERON PHARMA4 citations82
US11045522B2Jun 29, 2021

Glucagon-like peptide 1 receptor agonists and uses thereof

REGENERON PHARMA3 citations73
US11884736B2Jan 30, 2024

Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)

REGENERON PHARMA2 citations72
US12421317B2Sep 23, 2025

Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies

REGENERON PHARMA0 citations62
US12139546B2Nov 12, 2024

Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

REGENERON PHARMA0 citations62
US12090193B2Sep 17, 2024

Glucagon-like peptide 1 receptor agonists and uses thereof

REGENERON PHARMA0 citations62
US12269889B2Apr 8, 2025

Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels

REGENERON PHARMA0 citations61
US11498970B2Nov 15, 2022

Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels

REGENERON PHARMA0 citations61
US11708416B2Jul 25, 2023

Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

REGENERON PHARMA0 citations58
US10995146B2May 4, 2021

Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

REGENERON PHARMA0 citations58
US12280124B2Apr 22, 2025

Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof

REGENERON PHARMA0 citations52
US10640566B2May 5, 2020

Nucleic acid molecules encoding antibodies to the human glucagon receptor

REGENERON PHARMA0 citations51

OKAMOTO HARUKA

1 patent

REGENERAN PHARMACEUTICALS INC

1 patent

SUMITOMO ELECTRIC INDUSTRIES

1 patent